Medullary thyroid carcinoma – case reports


MUDr. Andrea Jurečková

Klinika komplexní onkologické péče, Masarykův onkologický ústav, Brno



Two case reports of patients with metastatic medullary thyroid carcinoma treated with tyrosine kinase inhibitors as a 1st line treatment are presented. The effectiveness of the treatment is compared - long-term treatment response in patient with early detected metastatic disease versus quick progression in patient with late diagnosis of advanced carcinoma and large proportion of metastatic lesions.


Key words

medullary thyroid carcinoma, targeted therapy, vandetanib, cabozantinib



The full article is only available to subscribers

Become a regular subscriber to our Oncological Review...